This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Harnessing a novel mechanism for HIV eradication with a new class of bifunctional molecules. Modern antiretroviral therapies (ARTs) efficiently block…
molecule
3 months ago ●
5 mins read
In September 2022, deucravacitinib (Sotyktu), a first-in-class oral, allosteric tyrosine kinase 2 (TYK2) inhibitor for moderate-to-severe plaque psoriasis, was approved…
Article
8 months ago ●
7 mins read
Preclinical validation for IRAK4 inhibitors for dermatology from activity in human biopsies. Interleukin-1 receptor-associated kinase (IRAK4) is downstream of toll-like…
molecule
3 months ago ●
5 mins read
Abstract. Voxelotor, a gram-daily reversible covalent aldehyde drug, is an approved first-in-class oral drug that prevents the hemoglobin polymerization that…
Article
8 months ago ●
7 mins read
Drug Hunter Reviewer Commentary. With over two decades of experience in neuroscience drug discovery, Drug Hunter reviewer Jake Schwarz says…
molecule
2 months ago ●
7 mins read
The real magic happens when chemists can integrate computational models into their assay cascades, thanks to trust in their predictions.…
Article
8 months ago ●
10 mins read
Load More
